Diffuse large B-cell lymphoma: A retrospective study from a regional care center in South India.

Introduction: Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma whose outcomes have significantly improved with rituximab in addition to anthracycline-based chemotherapy.

Objective: This study aimed to study the epidemiology, treatment, and outcomes of patients with DLBCL.

Materials And Methods: A total of 526 patients diagnosed with DLBCL between 2006 and 2015 were retrospectively analyzed.

Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.

Chronic myeloid leukaemia (CML) is a myeloproliferative disorder. Over the years many prognostic models have been developed to better risk stratify this disease at baseline. Sokal, Euro, and EUTOS scores were developed in varied populations initially receiving various therapies.